Medical Therapies Limited



Medical Therapies Limited (ASX:MTY) Announce Positive Interim Results From Cuprindo Phase I Clinical Trials

🕔2/15/2008 2:07:27 PM 3608

Medical Therapies Limited (ASX: MTY), today announced that it has completed its 'first-in-human' clinical trial of Cuprindo(tm) to determine its safety, tolerability and systemic absorption characteristics. The Phase 1 trial was conducted using a topical suppository formulation in preparation for a planned efficacy study in proctitis patients.

Read Full Article

Medical Therapies Limited ASX: MTY - Investor Presentation - Ms Maria Halasz , MD and CEO

🕔6/14/2007 2:02:00 PM 1548

Medical Therapies Limited (ASX: MTY) - Investor Presentation - Ms Maria Halasz , MD and CEO; Boardroomradio is pleased to announce that Medical Therapies Limited (ASX: MTY) has published an audio file.

Read Full Article


  • This Page Viewed: (Last 7 Days: 1) (Last 30 Days: 8) (Since Published: 1622) 

Company Data

    Principal Sector
  • Health & Pharm 
  • Principal Industry
  • Biotechnology